Join
Live feed
·
INSIDERFilingvia Quantisnow
Jounce Therapeutics Inc. logo

SEC Form 4: Trehu Elizabeth sold $57,700 worth of shares (8,383 units at $6.88), decreasing direct ownership by 9% to 85,202 units (for withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.
JNCE· Jounce Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JNCE (Jounce Therapeutics Inc.) and more on Quantisnow.